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Material and Methods: A bespoke QA programme was 
created for the 5 anatomical treatment sites which included 
spine and nodal metastasis. Prior to treatment centres were 
required to complete a QA process which included planning 
benchmark cases. Participating centres were provided with a 
pre-outlined planning CT. They created PTV expansions using 
local protocols. The centres were then required to create a 
plan based on a 30 Gy in 3 fraction prescription for the nodal 
case and a 24 Gy in 3 fractions prescription for the spine 
case. Both cases required a D95% of the prescription dose for 
the PTV coverage whilst ensuring OAR tolerances were met. 
All planning benchmarks were submitted and centrally 
analysed using VODCA 5.4 plan review software. The 
coverage of the PTV and CTV with the prescription dose, 
doses to OARs and measures of conformity were calculated. 
The values for the different submissions were compared to 
ensure plans were of suitable quality and comparable across 
different treatment platforms.  
 
Results: A total of 10 and 11 plans were submitted for the 
spine and nodal benchmark cases respectively, including all 4 
NHS cyberknife centres and the remainder using VMAT. 27% 
of the nodal and 18% of the spine plans had unacceptable 
deviations and the centres were given feedback and asked to 
resubmit their QA. The PTV coverage and max dose were 
compared for the different treatment techniques with the 
standard deviation. These can be seen in the table below. 
 
 
 
A 2 tail Mann-Whitney test was performed on the PTV 
coverage data for both plans. This indicated that there was a 
significant difference between cyberknife and VMAT plans 
(p=0.02).  
 
Conclusion: Cyberknife plans on average achieved superior 
PTV coverage when compared to VMAT plans. This was more 
evident for the spine PTV and nodal PTV 1, with both volumes 
being close to OARs, than for the nodal PTV 2 where OARs did 
not restrict the dose . The VMAT plans involved larger PTV 
and PRV expansions which would partly explain the difficulty 
in achieving the required PTV coverage. However, several of 
the VMAT plans had similar PTV coverage to the cyberknife 
plans, hence the greater variation in PTV coverage of the 
VMAT plans may reflect possible inexperience in SABR 
planning for some centres. Following resubmissions, all 
centres participating in the CtE programme have been able to 
produce acceptable benchmark plans regardless of treatment 
platform.  
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Purpose or Objective: Preclinical studies are critical steps in 
the medical research process, normally requiring dedicated 
instruments. For those centers in which both preclinical 
research and clinical practices are conducted, the dosimetric 
feasibility of small animal irradiation with clinical devices 
may be of economical and scientific interest. The aim of the 
present work is to investigate the feasibility of small animal 
irradiation with Tomotherapy Hi-Art by analyzing dosimetric 
results, toxicity and tumour response in xenograft models. 
 
Material and Methods: Xenograft models were established by 
injecting human derived glioblastoma multiforme stem-like 
cells in immunocompromised NOD-SCID mice both 
subcutaneously (10 groups) and intracranially (7 groups). Mice 
of each group were anesthetized and placed in a plexiglas 
cage pie to perform CT scans for treatment planning 
purposes. Target volumes and organs at risk (OARs) where 
outlined on CT scans: for subcutaneous xenografts, target 
volumes were delineated on the right flank and contoured 
OARs were lung and gastro-intestinal tract. For orthotopic 
models, a ring-shaped target structure was delineated on 
mice’s head; contoured OAR was lung. Three fractionation 
schedules were tested: 4Gy/1 fraction, 4 Gy/2 fractions and 
6 Gy/3 fractions. TomoDirect IMRT technique was applied, 
with gantry fixed at 0° and 180. 5 subcutaneous and 1 
orthotopic groups of xenografts were irradiated by covering 
the target volume with a 0.6 cm bolus layer in order to 
reduce the impact of the build-up effect. Irradiations 
originally performed without bolus were simulated with a 0.6 
cm virtual bolus in order to compare dosimetric results. 
Before irradiation, a MVCT image has been acquired to 
correct irradiation setup. Mice were observed daily and 
sacrificed when they showed signs of suffering or when 
tumour volume reached the established endpoint. Different 
radiobiological outcomes were evaluated, regarding both 
radiotoxicity (survival experiments) and tumour response 
(assessed by caliper or bioluminescence imaging), comparing 
irradiated mice as respect to their controls. 
 
Results: Dosimetric results showed that the presence of the 
bolus layer significantly impact the maximum dose received 
by both target volumes and OARs (t-test, p<0.05). Survival 
analysis showed that irradiation with a dose of 6 Gy in 3 
fractions in the presence of a bolus layer prolong mice 
survival (Log-rank test, p<0.02), showing to be the safest 
irradiation protocol. Tumour volume response and mice 
survival were significantly different in irradiated xenografts 
as compared to their controls (t-test, p<0.03; Log-rank, 
p<0.05) demonstrating also the radiobiological potential of 
Tomotherapy in inducing tumour growth stabilization. 
 
Conclusion: Tomotherapy systems may be a useful mean for 
small animal irradiation.  
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Purpose or Objective: To evaluate the dosimetric properties 
of acrylonitrile butadiene styrene (ABS) and polylactide (PLA) 
plastics, and their suitability for bolus printing applied in 
high-energy radiotherapy to overcome the skin-sparing 
effect. 
 
Material and Methods: The measurements were performed 
with Vero® System (Brainlab AG, Feldkirchen, Germany) 
delivering 200 monitor units (dose rate of 500 MU/min) with a 
6 MV photon beam, 5x5 cm open field with 90-degree gantry 
angle at 100 cm surface to surface distance (SSD) on a water-
equivalent RW3 slab phantom in three configurations: 
without bolus, with a commercial bolus and with the eight 3D 
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printed boluses. Gafchromic EBT3 film (International 
Specialty Products, Wayne, NJ) placed between phantom 
slabs provided dose profile measurements. An Epson 
Expression Scanner 10000 XL (Epson, Long Beach, CA) was 
used to determine the optical density of the films and film 
analysis were performed using Film QA Pro software (Ashland 
Inc., Bridgewater, NJ). 
 
Results: The mean value of Hounsfield unit (HU) of the 3D 
printed boluses was provided analyzing their Computed 
Tomography (CT) scans. Negative HU were due to the air gap 
inside the infill pattern. The mean HU increased with the 
percentage infill, resulting in higher bolus density (Tab. 1). 
This reduced the distance from the surface of the phantom 
where the maximum dose occurs (dmax) as shown in Fig.1. 
Build-up peaks shifted towards the phantom surface when 
any bolus was used. ABS and PLA boluses with an infill 
percentage of 40% had comparable performance to the 
commercial bolus. 
 
 
 
 
 
Conclusion: The dosimetric analysis of the 3D printed flat 
boluses showed that they can decrease the skin-sparing as a 
commercially available bolus. The performed analysis 
accurately describes the physical behavior of these plastic 
materials, in order to represent them in treatment planning 
system for precise treatment delivery. Moreover, patient-
specific boluses could be outlined from patient CT images 
and 3D printed, thus shaping the actual anatomy of the 
patient. This procedure may represent a viable alternative to 
commercially available conventional boluses, potentially 
improving the fitting between bolus and skin surfaces. 
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Purpose or Objective: Multicentre comparisons of 
dosimetrical parameters are important to ensure the same 
quality of the treatment in radiotherapy centres, and allow 
to identify systematic errors. In this study, small fields 
dosimetric parameters were collected in a national context 
using a common acquisition procedure and a specific 
dosimeter. The aim of this study was to provide indicative 
values for each Linac model for small field dosimetry 
measurements. This can be useful for centres with reduced 
experience in small fields dosimetry. 
 
Material and Methods: Thirty-four centres with different 
LINACs joined this project: 2 Siemens, 7 Elekta Agility, 6 
Elekta Beam Modulator, 12 Varian CLINAC and 7 Varian 
TrueBeam. All measurements were performed using the new 
IBA unshielded silicon diode RAZOR and the Stealth flat 
ionization chamber fixed on the gantry as reference. The 
RAZOR was positioned at 10cm depth in water phantom and 
SSD=90cm. In and Cross-line beam profiles ranging from 0.6-
5cm (nominal field size). The actual in-plane (I) and cross-
plane (C) FWHM were considered to calculate the effective 
field size, defined as (A*B)^0.5. Ouput factors (OF) were 
calculated and normalized to the 3x3 cm2. OF were 
calculated for both nominal (OF_N) and effective (OF_E) field 
sizes. The penumbra width was defined as the distance 
between the 80% and 20% isodose levels. Two identical diodes 
were adopted to speed up the data collection. 
 
Results: OF_N were in agreement over the different models 
up to 1x1 cm2 field size. Higher agreement was obtained 
with OF_E, for the smallest fields different trends were 
obtained depending on vendors and models, see Fig.1. 
Penumbra measurements were in agreement each other for 
each field size and accelerator model. 
 
